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c TÜBİTAK
⃝
doi:10.3906/kim-1510-2

Review Article

Prostereoisomerism and biological activity: possible implications for drug design
Sosale CHANDRASEKHAR∗
School of Biomedicine, Far Eastern Federal University, Russky Island Campus, Vladivostok, Russian Federation
Received: 01.10.2015

•

Accepted/Published Online: 13.12.2015

•

Final Version: 21.06.2016

Abstract: Prostereoisomerism (PIM), representing a subgroup within the achiral class of molecules, is manifested in
a chiral environment. Although this is regardless of the orientation of the prostereoisomeric (PIC) molecule, PIM is
manifested most emphatically in relation to a chiral surface (‘two-dimensional chirality’). Then PIM is tantamount to
‘de facto chirality’ as attachment of the PIC molecule to the surface leads to diastereomeric possibilities (cf. Ogston’s
hypothesis). Furthermore, the formation of host–guest complexes requires a steric complementarity between the component molecules. The fact that the weak dispersive forces involved therein require an optimum distance implies a ‘snugness
of fit’ criterion. This further implies that a chiral host prefers a chiral guest molecule, and a chiral surface prefers a PIC
molecule as substrate. These indicate a general stereochemical criterion for host–guest complexation that is particularly
relevant to the case of biological receptors. Indeed, a survey of several known achiral drug molecules indicates that they
generally possess at least one PIC moiety, lending credence to the above arguments. Thus, it would appear that PIM
represents a maximum level of molecular symmetry for biological activity to be manifested eﬃciently.
Key words: Host–guest, Ogston, prochiral, 2D-chirality, van der Waals

1. Introduction
The concept of prostereoisomerism (henceforth ‘PIM’) is well known to students of organic stereochemistry in the
context of the historic Ogston hypothesis. 1−6 In the most general sense, PIM manifests itself when certain achiral
(guest) molecules are placed in a chiral environment. In the archetypal case, the guest molecule possesses two
identical and two nonidentical groups bonded to a tetrahedral center (1, Scheme 1). In an achiral environment,
the two identical groups are energetically equivalent, but this degeneracy is lifted in a chiral environment (2).
Thus, the interaction with the chiral environment renders the equivalent groups nonequivalent, and the guest
molecule per se becomes chiral.
This potential for acquiring chirality in certain achiral molecules is captured by the term PIM. The above
tetrahedral center was thus termed ‘prochiral’, although the more general term ‘prostereogenic’ is currently
preferred. PIM may also be displayed by unsymmetrical planar molecules, the two planes (faces) of which
become prostereogenic in a chiral environment (3). (Formally, in the context of PIM, the above terms ‘identical’
or ‘equivalent’ and ‘nonidentical’ or ‘nonequivalent’ would be termed ‘homotopic’ and ‘heterotopic’ respectively,
following the original suggestion of Mislow and Raban.) 4
The above discussion indicates that the interaction of a prostereogenic molecule with a chiral environment
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leads to unique stereochemical consequences. These, of course, derive from the definition of PIM itself. Moreover,
PIM is often defined in terms of a practical act of discrimination between equivalent groups or faces, usually
via a reaction leading to stereoisomeric products. However, PIM can also be discerned by a simple act of
inspection—possible because the human performing it possesses a chiral sense!
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Scheme 1. Molecules exhibiting prostereoisomerism: 1 possesses a tetrahedral center with two heterotopic ligands (R),
2 being a cartoon representation of 1 in a chiral environment (indicated by the ‘S’ shaped curved line); 3 shows a planar
molecule (inden-1-one) with heterotopic faces relative to a chiral environment represented by the chiral acyclic molecule
at the top (CABXY).

In the following section, various aspects of PIM, particularly vis-à-vis a chiral environment are discussed.
The object of this exercise is to understand the stereochemical requirements for the interaction of biologically
active molecules with their chiral receptors. The critical importance of chirality for biological activity is, of
course, well recognized. However, the possible importance of PIM in biological activity has not so far been
explored in any depth.
PIM is indeed well-served by authoritative reviews, 1−3 but this paper deals with PIM in the context
of host–guest interactions particularly relevant to biological phenomena. Furthermore, there is controversy as
to whether the term ‘prostereogenic’ is applicable to molecules or only to moieties (e.g., centers and faces),
although there is apparently no confusion if only one of these is present. 2 In fact, ‘prostereoisomeric’ (PIC)
seems appropriate for a whole molecule, and is thus employed henceforth in this paper.
2. Discussion
2.1. General considerations related to symmetry
PIC molecules apparently define a middle ground between ‘achiral’ and ‘chiral’. As seen in the above case with
a tetrahedral center (1), the presence of two nonequivalent groups is essential; these molecules still possess
a plane of symmetry, although defining a subclass among achiral molecules in general. The strength of the
above interaction between the guest molecule and the chiral environment would, of course, depend on various
factors, but particularly on the nature of the groups and the chiral environment, the number of interactions,
etc. The following ‘gedanken experiments’ oﬀer interesting insights into the manifestation of PIM under various
conditions.
Thus, even a highly symmetrical molecule such as methane (CH 4 ) may become a chiral moiety within a
chiral environment (4, Scheme 2). This requires that the molecule be essentially restrained from tumbling, which
would ‘scramble’ the relative positions of all the four hydrogen atoms. However, if the molecule is constrained
within a chiral pocket, all the four hydrogen atoms become nonequivalent: they would then, in principle, display
four distinct resonances in the proton NMR spectrum.
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Scheme 2. Cartoon representations of a methane molecule (4) and a PIC molecule (5) in a chiral environment
represented by the surrounding contour; interchange of all groups (or atoms) within any two pairs of such groups
around the tetrahedral centers would correspond to the tumbling of the molecules.

In fact, this would occur even if the molecule were tumbling, but slowly on the NMR time scale. Putative
attachment of the CH 4 molecule at one of its hydrogens to the chiral pocket would also lead to the nonequivalence
of the remaining three hydrogens, as long as the rate of rotation of the CH 3 moiety were slow on the NMR
time scale. Interestingly, this contrasts with the case of a PIC molecule (5), essentially because of its lower
symmetry.
Thus, the equivalent groups in a PIC molecule would become nonequivalent in a chiral environment even
if the included molecule were freely tumbling. This is due to the presence of the two nonequivalent groups,
which provide a ‘stereochemical fix’ at the tetrahedral center. Thus, any tumbling event that interchanges
the positions of the equivalent groups within the chiral environment also interchanges the positions of the
nonequivalent groups. Since the latter interchange generates putative diastereomeric interactions (with the
chiral environment), tumbling can never lead to the degeneracy of the molecule as a whole.
2.2. The Ogston hypothesis and two-dimensional chirality
The above discussion indicates that the interaction of an achiral molecule with a chiral environment leads
to consequences that depend essentially on the symmetry level of the molecule, but also on the nature of
the interaction (the molecule being constrained or not). However, it appears that the nature of the chiral
environment is also significant, an insightful conclusion that was apparently presaged by the Ogston hypothesis,
often considered a landmark in the history of stereochemistry. 5−8 Intriguingly, however, although the proposal
led to the evolution of the idea of PIM itself, a few of its subtleties apparently remain to be elaborated. (It now
appears that the idea of two-dimensional chirality is key to understanding the Ogston hypothesis, vide infra.)
The original Ogston proposal dates back to a period when modern stereochemical ideas were still evolving,
and the concept of a chiral environment within a pocket of the host molecule would perhaps have been a novelty.
The hypothesis is best exemplified by the enzymatic phosphorylation of glycerol (6, Scheme 3) to produce R (-)-glycerol-1-phosphate (7), which involves distinguishing between the two terminal hydroxyl groups in the
PIC glycerol molecule. 5,6 Although the formation of a chiral product at a chiral enzyme active site needs little
agonizing, it is a testament to the insightfulness of the approach that mechanistic details were indeed pursued.
In fact, this is also an opportune juncture to refer to a remarkable early paper by Easson and Stedman,
which eerily presaged many of the later developments related to the Ogston hypothesis and PIM in general. 7
These authors (although perhaps arbitrarily) assumed a three-point binding mode in order to relate the
biological activity of various molecules in terms of their stereochemistry. They presciently proposed that
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chirality in of itself is not a prerequisite for activity, and concluded that PIC molecules (by current terminology)
would be structurally adequate for eﬃcient binding to a chiral receptor. Experiments involving analogues of
adrenaline and miotine lent impressive support to their ideas, these clearly constituting pioneering studies on
the stereochemistry of drug action.

Scheme 3. The enzymatic stereoselective O− phosphorylation of glycerol (6) to form R -(-)-glycerol-1-phosphate (7);
the Ogston three-point attachment proposal is depicted in I (via the dotted lines); the trapezoidal represents a chiral
surface with (nonidentical) attachment sites A, B, and C; the alternative strained diastereomeric interaction is shown in
II alongside; the reactants (ATP and glycerokinase enzyme) and byproduct ADP are not shown for simplicity.

2.3. Chiral surfaces and planar chirality
The Ogston mechanism involved a three-point attachment of a PIC molecule to, essentially, a chiral surface, i.e.
a chiral pocket in which one face is shielded and hence inaccessible (cf. I). Then a minimum of three interactions
is necessary unequivocally to exclude one of the two equivalent groups at the prostereogenic center from the
reaction site. (Thus, a two-point attachment would not distinguish between the two equivalent groups, inasmuch
as the unattached groups would not interact with the chiral surface. Note also that it takes a minimum of three
points to define a surface!)
Therefore, the Ogston hypothesis invoked the idea of what is now understood as two-dimensional
chirality. 2,3,9,10 This is possible in the case of an unsymmetrical planar object as long as the object is not
moved out of the plane (Scheme 4). Thus, within the general plane occupied by it, the unsymmetrical planar
object (III) would be nonsuperimposable on its mirror image (IV). This ‘stereochemical parlor trick’, however,
acquires practical significance when a chiral pocket functions as a de facto surface (vide supra)!

Scheme 4. Two-dimensional (III and IV) and planar (V and VI) chirality; the former defines a chiral surface.

A chiral surface would be a special case of ‘planar chirality’, which is defined in terms of a group of
four atoms in a plane, and a fifth ‘pilot’ atom (Y) above or below the plane (V and VI). 9,10 The diﬀerence,
essentially, is that in the case of planar chirality the restriction on moving the object out of the plane is
unnecessary, because of the presence of the pilot atom.
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Conversely, therefore, the Ogston hypothesis implies that binding sites in biological reactions may be
viewed essentially as chiral surfaces. However, in the light of current knowledge about the three-dimensional
structures of biological macromolecules, the Ogston hypothesis amounts to ‘overkill’ ! Thus, as seen above,
a consideration of the overall three-dimensional space within a chiral (host) pocket indicates that the two
equivalent groups at a prostereogenic center in a guest molecule may be distinguished even if the molecule were
to be freely tumbling! Of course, binding interactions would (generally) increase the energy diﬀerence between
the alternative bound groups at the reaction center. In principle, however, they are not necessary if the spatial
environment in the chiral pocket is suﬃciently demanding in terms of selectivity.
On the other hand, such an idealized view of stereoselectivity needs to be tempered by mundane
considerations involving current knowledge and experience. Thus, host–guest interactions generally involve
precise binding sites leading to the formation of intermediate complexes of defined structure. These may indeed
represent minima along reaction contours in potential energy space. On this basis, we are now back at the
Ogston hypothesis!
Thus, although the immobilization of a PIC substrate at an enzyme active site is, in principle, unnecessary
in order to distinguish between the two equivalent groups (or faces), the fact is that reactions at such sites do
occur via bound intermediates. In that case, the question arises as to the minimum number of interactions that
are necessary to distinguish between the equivalent groups (or faces). The answer would be ‘three’, assuming
that the binding site can be considered as a chiral surface.
The view of an enzyme active site as a chiral surface appears unexceptional, considering that the binding
site somewhat resembles a mousetrap, i.e. one side is completely shielded, so the entry and exit of the substrate
are restricted to the opposite side! This may seem an oversimplification, inasmuch as it ignores weak dispersive
interactions (e.g., van der Waals) between the substrate and the walls of the active site cleft. However, the
Ogston mechanism clearly focuses on the three strongest interactions as three functional sites in the substrate
are involved!
All the same, the above mousetrap analogy needs due caution, as indicated by an intriguing paper by
Mesecar and Koshland on isocitrate dehydrogenase. 8 In this enzyme, the active site is a three-dimensional
cleft that is complementary to a hypothetical trigonal bipyramid. This can accommodate the same three (of
the four) groups linked to the C2 stereogenic center in the substrate enantiomers, but from opposite sides
of the trigonal surface! Essentially, the binding of the fourth group at C2 then determines stereospecificity,
indicating a departure from the Ogston three-point mechanism. (Thus, the enzyme can bind either L-isocitrate
or D-isocitrate, although the latter along with Mg 2+ .)
Intriguingly, in fact, this may well indicate that three-point binding applies to PIC substrates and fourpoint binding to chiral substrates! Of course, a PIC substrate may lead to a chiral product (and vice versa),
noting that enzymes bind both reactants and products (whatever the direction of the equilibrium). However, the
enzyme could then undergo conformational changes during the reaction, and alternate between the three-point
and four-point modes as appropriate. Furthermore, in fact, these preferential binding modes likely indicate that
eﬃcient binding is based on size variation between the bound groups, as argued below.
Thus, a chiral substrate possesses four diﬀerent groups at a tetrahedral center (generally), and a combination of any three of these may well oﬀer a similar degree of size variation. The three-point binding mode
would not then distinguish between the two enantiomeric substrates eﬃciently. (Of four groups A, B, C, and
D, both the combinations A, B, C and B, C, D, say, could bind with similar eﬃciency; in terms of size, A < B
< C < D.)
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Such happenstance, however, is ruled out in the case of a PIC substrate, as two of the four groups would
be identical (say A, B, C, C’, with C = C’). Then only one combination would aﬀord size variation (say A, B,
C) along with stereochemical complementarity, which would also distinguish between the heterotopic groups (C
and C’, thus ruling out A, B, C’).
Even so, the implications of the above four-point mechanism in the case of a PIC substrate are interesting.
This can bind in two possible modes at the bipyramidal cleft: from both sides of the trigonal surface, but
employing diﬀerent heterotopic ligands in each case.
In fact, this also relates nicely to the Prelog–Helmchen nomenclature for heterotopic ligands, e.g., H Re
and H Si , the topicity on each side of the chiral surface in the bipyramid being opposite to the other. 2,11 These
modes of binding would be diastereomeric, however, as the two heterotopic ligands would experience diﬀerent
environments in the cleft. (These correspond to the fourth group in the isocitrate case above; the reader is
referred to the original paper for the spatial representation of these ideas.) 8
In any case, the Ogston proposal holds its ground as it defines a minimum requirement at a chiral
surface (a four-point binding mechanism being not necessarily precluded)! In addition, the ability of isocitrate
dehydrogenase to bind both isocitrate enantiomers as above is intriguing (in evolutionary terms), although
further speculative discussion is beyond the scope of this paper.
2.4. PIM as ‘de facto chirality’
The above extended discussion leads, broadly, to the view that the interaction of a PIC molecule with a chiral
environment depends crucially on the nature of the chiral environment. More pointedly, it appears that if the
PIC molecule is interacting with a chiral surface, the former has all the attributes of a chiral molecule. This is
because the three-point attachment of the molecule involving either of the two equivalent groups leads to the
formation of diastereomeric complexes (cf. I and II, Scheme 3). On this basis, PIM should be viewed as ‘de
facto chirality’ !
Chiral surfaces, in fact, may be viewed as resulting from the projection of three-dimensional chirality
onto two dimensions (8 → 9, Scheme 5). Analogously, PIM can also be projected onto two dimensions (10
→ 11), noting that two enantiomeric surfaces result as the projection can be relative to either of the two R 1
groups. Moreover, intriguingly, chirality and PIM cannot be distinguished in the resulting projections!
This is because one of the four groups around the stereogenic and prostereogenic centers is ‘lost’ in the
projections, but this is irrelevant in the context of planar chirality. Interestingly, these arguments are practically
relevant to the ‘mousetrap analogy’ (vide supra) of a chiral binding site: the group that is lost in the projection
is the unbound group that would ‘stick out’ of the site.
These geometric analogies oﬀer support to the view that PIM is de facto chirality in relation to a chiral
surface. The essential diﬀerence, of course, is that chirality gives rise to two enantiomeric forms, whereas PIM
does not give rise to any isomeric forms per se. Thus, the potential of PIM is only realized in the presence of
external chirality; in particular, there are two distinct ways of orienting a PIC molecule vis-à-vis a chiral surface
(cf. I and II, Scheme 3).
Interestingly, these arguments also apply to the above four-point model (Section 2.3). In this case, the
PIC molecule fits into either side of the chiral surface in the trigonal-bipyramidal cleft. However, as noted
above these binding modes would be diastereomeric, again implying that the PIC molecule is de facto chiral in
the cleft. (Furthermore, these diastereomeric interactions are additional to those arising from the three-point
attachment at the trigonal surface, cf. I and II.)
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Scheme 5.

The projection of tetrahedral chiral (8) and PIC (10) molecules onto a surface (represented by the

trapezoidal); while 10 leads to an enantiomeric pair of chiral surfaces (only 11 shown), 8 leads to four distinct chiral
surfaces (only 9 shown) corresponding to the faces of a tetrahedron.

2.5. Chiral binding sites and snugness of fit
These arguments have intriguing consequences in the light of the fact that chirality plays a crucial role in
biomolecular interactions. This is generally interpreted in the context of selectivity and specificity, implying
that between two enantiomers of a substrate a biological binding site preferentially interacts with only one
of them. However, these considerations also imply that a chiral binding site prefers to interact with a chiral
rather than an achiral substrate molecule (vide infra). This is based on straightforward considerations of shape
complementarity and snugness of fit.
Thus, a chiral binding site may be defined in terms of four binding pockets distributed in three-dimensional
space. The pockets would be located at the corners of a tetrahedron, for shape complementarity relative to
a chiral tetrahedral center. Furthermore, the pockets would all diﬀer, in either size or the nature of binding
(chelation, hydrogen bonding, etc.). Let us designate the binding pockets in terms of (say) size as S (small),
M (medium), L (large), and X L (extra large). Now a tetrahedral substrate would perforce possess four groups
with the same attributes, and hence be chiral (12, Scheme 6).
A critical caveat in the above arguments is that they imply a close matching of steric size but also preclude
a mismatch, even if it were not sterically forbidden! Thus, although it is intuitively obvious that a large group
cannot fit into a small pocket (L in S), it is less obvious that a small group fitting into a large pocket may lead
to an ineﬃcient interaction (S in L). This is because the weak interactions that generally mediate the binding of
substrates in hydrophobic pockets possess an optimal distance, below which steric crowding sets in, and beyond
which the weak attractive forces (e.g., van der Waals) wane rapidly. 12,13
Clearly then a chiral carbon centered molecule CSMLX L would bind more eﬃciently to a complementary
site than would an achiral analogue (say) CSMLS (13). In the latter case, a small group (S) would be lodged
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in a large pocket (X L ); although not sterically forbidden, it would be ineﬃcient in terms of the minimization
of the overall energy. (In other words, ‘snugness of fit’ is crucial for eﬃcient binding or complexation.)
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Scheme 6. Chiral (12) and PIC (13) molecules with complementary binding pockets represented by partial circles of
varying size (in 13 one of the S groups is mismatched with an X L pocket); a projection of 13 to generate a chiral surface
is shown in 14.

These arguments may now be extended to the binding of a PIC substrate to a chiral surface (14). The
chiral surface may be analogously characterized by three binding sites S, M, and L. By arguments similar to
the tetrahedral case discussed above, the chiral surface would preferentially bind molecules of the configuration
CSMLY, where ‘Y’ designates an additional group that is not involved in the binding.
Interestingly, if Y is diﬀerent from the other three groups, the molecule will be chiral; however, if Y is
the same as one of the other three groups (say S), the molecule would be PIC. Clearly, this is the highest level
of symmetry allowed for the substrate, for eﬃcient binding at a chiral surface.
2.6. Planar systems
The above discussion has focused on tetrahedral substrates for convenience and ease of representation. The
ideas may be extended to the case of planar molecules possessing prostereogenic faces (Scheme 7), although
with additional caveats related to their symmetry characteristics. These derive from the requirement that
these planar systems be complementary to a chiral surface, i.e. they essentially possess the same symmetry
characteristics. As a chiral surface, by definition, cannot be dislocated from its plane (‘flipped over’), this
rules out the presence of a C2 axis of symmetry, e.g., naphthalene. (In these cases, the mirror images are
superimposable even without flipping over and so their contours do not define a chiral surface.)
Thus, these molecules are essentially characterized by unsymmetrical contours that give rise to edges
of varying size and shape. The molecules may bind on a chiral surface that is defined by niches along the
surrounding walls of a chiral cavity that are complementary to these edges. This would then render the top and
bottom faces of the molecule nonequivalent or heterotopic.
As noted above, PIM can be considered as de facto chirality with reference to an external chiral surface.
In the case of tetrahedral systems, the three nonequivalent groups around the prostereogenic center can be
represented as S, M, and L. In the case of planar systems too, the edges along the unsymmetrical contour can
be divided into sections of varying size based on approximate curvature (Scheme 7). The above mentioned
snugness-of-fit criterion again indicates that a PIC molecule would be an appropriate substrate at a chiral
surface. (In Scheme 7, note that the included indenone molecule will not fit eﬃciently into the cavity in any
other orientation.)
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2.7. Overall assessment and implications for drug design
The above discussion on certain stereochemical concepts and principles indicates the close analogy between
chirality and PIM. Most importantly, application of the snugness-of-fit criterion indicates that chiral receptors
would preferentially interact with chiral or PIC substrates for eﬃcient binding. It was also mentioned early on
that PIM forms a subclass of achiral molecules in general. Taken together, these arguments imply that PIM
represents the highest level of molecular symmetry permissible for biological activity to be manifested eﬃciently.
(In the case of planar systems, additionally, the absence of a C2 axis is indicated, vide supra.)
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Scheme 7. Cartoon representation of a planar molecule with prostereogenic planes (inden-1-one) ensconced in a chiral
cavity (surrounding contour); X and Y represent points of attachment for the undefined curved bridges, and S, M, and
L indicate the small, medium, and large sections (respectively) that are complementary to the edges of the cavity.

These arguments, of course, are predicated on the assumption that symmetry is the predominant criterion
in determining the activity. This is clearly an oversimplification inasmuch as biological activity is determined
by a whole host of properties relating to corresponding molecular features. However, the present discussion
represents an attempt to disentangle stereochemical considerations, particularly concerning symmetry alone,
from the skein of determining properties. (Note, also, the above requirement of eﬃciency; this implies that
although the deduced symmetry criteria are not inviolable, following them leads to improved activity.)
Essentially, therefore, the question being addressed is: what are the molecular symmetry criteria for
biological activity to be manifested eﬃciently, other features being constant? Although this is a hypothetical
question, if the symmetry criteria can indeed be disentangled, they can be introduced into the design of new
molecules of biological interest, e.g., drugs. The resulting strategy can thus become a part of the principles of
drug design in general.
2.8. PIM and known drug molecules
In view of the above considerations, it is interesting to note that a number of known achiral drug molecules
display PIM. These are (inter alia): 14,15 dicyclidine (15, Scheme 8), dicyclidol (16), diphenidol (17), gemfibrozil
(18), pridinol (19), pyrrinol (20), (tetrahedral systems); carbamazepine (21), celecoxib (celebra; 22), diclofenac
(23), and triclosan (24) (planar systems). Whilst the tetrahedral systems possess a gem-disubstituted prostereogenic center, the planar systems possess at least one moiety with a prostereogenic plane (18 possesses both a
center and a plane). Almost always, this derives from an unsymmetrically substituted aromatic ring, with meta
and ortho substitution being quite common. (Several other cases have been discussed previously.) 1 Generally, it
appears symmetrically disubstituted systems are unknown (they would not display PIM). Interestingly, several
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commonly used drug molecules display PIM, e.g., acetaminophen (paracetamol), aspirin, and barbital (sodium
salt).
The above selection of molecular structures indicates that PIM may well be one of the determining factors,
generally speaking, in the occurrence of biological activity.

Scheme 8. Known drug molecules with prostereogenic centers (15–20) and planes (18, 21–24); note that 21 involves
amide resonance at the azepine nitrogen and so lacks a C2 axis.

2.9. Conclusions
Prostereoisomerism (PIM) defines a subclass among achiral molecules in general. By definition, PIM is manifested in the presence of an external chiral influence, which enables discrimination between the heterotopic
ligands or planes. Although this is independent of orientation within a chiral environment, PIM is most palpable with reference to a chiral surface (cf. Ogston’s three-point attachment hypothesis). Then PIM may be
considered as de facto chirality, as its attachment to a chiral surface leads to diastereomeric adducts.
The complexation of a substrate at a chiral binding site involves, inter alia, stereochemical complementarity between the substrate molecule and the features of the binding site cavity. It is then highly likely that
there is an optimum size for each of the three groups to be attached at the corresponding pockets on the surface.
This is because the weak dispersive forces generally mediating these interactions require an optimum distance
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for eﬃcient complexation to occur (‘snugness of fit’). This implies that a chiral cavity would prefer to bind to
either a chiral or, at the very least, a PIC molecule. (The latter particularly applies if the cavity is considered
as providing a chiral surface, as in the Ogston mechanism.)
These conclusions have an interesting bearing on biologically active molecules in general and the design of
drugs in particular. Intriguingly, in fact, a large number of known achiral drugs display PIM, thus representing
a possible vindication of the above ideas.
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